BlackRock Group’s Immunic IMUX Stock Holding History

BlackRock Group’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-9	Closed	-$14K	–	3027
2015 Q3	$14K	Buy	9 +2	+29%	+$10K	﹤0.01%	3008
2015 Q2	$60K	Buy	+7	New	+$66.8K	﹤0.01%	2852

Other funds holding IMUX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $46.4M AUM 13.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock Group's IMUX Position: Q4 2015 in Review

BlackRock Group sold out of Immunic (IMUX) in Q4 2015, closing a stake of 9 shares — an estimated $14K sold.

BlackRock Group first reported a position in IMUX in Q2 2015 and held it in 2 quarters. The position peaked at $60K in Q2 2015. 54 funds tracked by Wall St. Rank hold IMUX as of Q4 2015.

BlackRock Group reported no remaining Immunic position as of Q4 2015 after selling out during the quarter.
BlackRock Group sold 9 Immunic shares in Q4 2015, an estimated $14K.
BlackRock Group first reported a position in Immunic in Q2 2015 and held it in 2 quarters.
BlackRock Group's Immunic position peaked at $60K in Q2 2015.
54 funds tracked by Wall St. Rank held Immunic as of Q4 2015.

Based on BlackRock Group's 13F filing for Q4 2015, filed 11 Feb 2016.